Akers Biosciences (AKER) Reports Q3 Loss of $0.45/Share
Tweet
Share
E-mailGet Alerts AKER Hot Sheet
Join SI Premium – FREE
Akers Biosciences (NASDAQ: AKER) reported Q3 EPS of ($0.45), versus ($0.23) reported last year. Revenue for the quarter came in at $169.5 thousand, versus $453.3 thousand reported last year.
For earnings history and earnings-related data on Akers Biosciences (AKER) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Netflix climbs following Ackman stake, up 1.8%
- Fermi Inc. (FRMI) Reports Q2 Loss of $0.04
- Buda Juice, Inc. (BUDA) Reports Q2 EPS of $0.04
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
